Cicletanine: Difference between revisions
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
No edit summary |
||
Line 21: | Line 21: | ||
| routes_of_administration = Oral | | routes_of_administration = Oral | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
'''Cicletanine''' is a furopyridine low-ceiling [[diuretic]] [[medication|drug]], usually used in the treatment of [[hypertension]].<ref>{{citation|title=Genetic Hypertension|author= Jean Sassard|year= 1992|publisher=John Libbey Eurotext|url= http://books.google.com/books?vid=ISBN086196313X&id=v4E_g_D6xCwC&pg=PA547&lpg=PA547&ots=B9ysddtUaZ&dq=Cicletanine&ie=ISO-8859-1&output=html&sig=vvMWhzhfLCEG2t0V5yRgddNdKw8|id=ISBN 086196313X}}</ref> The drug is manufactured by [[Ipsen]] and marketed by Recordati (in France) under the trade name '''Tenstaten'''. | |||
==External Links== | |||
* [http://www.ipsen.com Ipsen Corporation] | |||
==References== | ==References== | ||
{{reflist|2}} | |||
{{ | |||
[[Category:Diuretics]] | [[Category:Diuretics]] | ||
[[Category:Drugs]] | [[Category:Sulfonamides]] | ||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Drug]] | |||
[[ |
Latest revision as of 01:31, 25 July 2014
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 97.3% |
Elimination half-life | 7.9 h |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C14H12ClNO2 |
Molar mass | 261.703 g/mol |
3D model (JSmol) | |
|
WikiDoc Resources for Cicletanine |
Articles |
---|
Most recent articles on Cicletanine Most cited articles on Cicletanine |
Media |
Powerpoint slides on Cicletanine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cicletanine at Clinical Trials.gov Clinical Trials on Cicletanine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cicletanine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cicletanine Discussion groups on Cicletanine Patient Handouts on Cicletanine Directions to Hospitals Treating Cicletanine Risk calculators and risk factors for Cicletanine
|
Healthcare Provider Resources |
Causes & Risk Factors for Cicletanine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cicletanine is a furopyridine low-ceiling diuretic drug, usually used in the treatment of hypertension.[1] The drug is manufactured by Ipsen and marketed by Recordati (in France) under the trade name Tenstaten.
External Links
References
- ↑ Jean Sassard (1992), Genetic Hypertension, John Libbey Eurotext, ISBN 086196313X
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Diuretics
- Sulfonamides
- Cardiovascular Drugs
- Drug